InsidersTradesSigma
Declaraciones totales
Empresa
▲ Compras (0 oper.)
▼ Ventas (54 oper.)
Historial del iniciado
DirectivoCompras declaradas
0
Ventas declaradas
54
Todavía no hay suficientes señales de compra con un horizonte T+90 consolidado para medir un historial.
Historial de señales
Browse the detailed record of transactions filed by Mahon Paul A, Executive Vice President, General Counsel, and Corporate Secretary. Director active across 1 company, notably UNITED THERAPEUTICS Corp. Cumulatively, 176 disclosures have been logged. Breakdown: 0 buy · 54 sells. Total volume traded: €23.6m. History available since 6 May 2021. The latest transaction was filed on 3 September 2026 (Levée d'options). Regulator: SEC (Form 4). All data is accessible without signup.
Companies and markets linked to Mahon Paul A
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declaraciones176 en total
8300 títulos@ 146,03 US$Common StockSEC:0001231589-26-000019:0
1545 títulos@ 478,9344 US$Common StockSEC:0001231589-26-000019:1
936 títulos@ 479,6575 US$Common StockSEC:0001231589-26-000019:2
2360 títulos@ 480,8613 US$Common StockSEC:0001231589-26-000019:3
1048 títulos@ 481,917 US$Common StockSEC:0001231589-26-000019:4
160 títulos@ 482,6625 US$Common StockSEC:0001231589-26-000019:5
200 títulos@ 483,8494 US$Common StockSEC:0001231589-26-000019:6
954 títulos@ 485,1228 US$Common StockSEC:0001231589-26-000019:7
598 títulos@ 486,4682 US$Common StockSEC:0001231589-26-000019:8
169 títulos@ 487,3622 US$Common StockSEC:0001231589-26-000019:9
10 títulos@ 488,32 US$Common StockSEC:0001231589-26-000019:10
320 títulos@ 490,885 US$Common StockSEC:0001231589-26-000019:11
2690 títulos@ 524,15 US$0.0063% mcap1.1% de su flujoCommon StockSEC:0001231589-26-000018:2
400 títulos@ 526,385 US$0.0009% mcap0.2% de su flujoCommon StockSEC:0001231589-26-000018:9
2690 títulos@ 146,03 US$0.0018% mcap0.3% de su flujoCommon StockSEC:0001231589-26-000018:0
5610 títulos@ 146,03 US$0.0037% mcap0.6% de su flujoCommon StockSEC:0001231589-26-000018:1
502 títulos@ 520,0331 US$0.0012% mcap0.2% de su flujoCommon StockSEC:0001231589-26-000018:3
1819 títulos@ 521,0406 US$0.0043% mcap0.7% de su flujoCommon StockSEC:0001231589-26-000018:4
787 títulos@ 522,0036 US$0.0018% mcap0.3% de su flujoCommon StockSEC:0001231589-26-000018:5
850 títulos@ 522,7838 US$0.0020% mcap0.3% de su flujoCommon StockSEC:0001231589-26-000018:6
192 títulos@ 523,6897 US$0.0005% mcap0.1% de su flujoCommon StockSEC:0001231589-26-000018:7
940 títulos@ 525,2504 US$0.0022% mcap0.4% de su flujoCommon StockSEC:0001231589-26-000018:8
120 títulos@ 527,21 US$0.0003% mcap0.0% de su flujoCommon StockSEC:0001231589-26-000018:10
1360 títulos@ 515,9303 US$0.0027% mcap0.6% de su flujoCommon StockSEC:0001231589-26-000017:3
8300 títulos@ 146,03 US$0.0047% mcap1.0% de su flujoCommon StockSEC:0001231589-26-000017:0
25 de 176 declaraciones
About Mahon Paul A
MAHON PAUL A is Executive Vice President, General Counsel, and Corporate Secretary at UNITED THERAPEUTICS Corp, where he is also listed as EVP & GENERAL COUNSEL. Across 135 filings in total, the most recent filings we hold span 2016-01-08 to 2026-04-16, with 0 EUR of buys and 8,862,264 EUR of sells, and the most frequent transaction nature is Levée d'options.
